Skip to main content Skip to main content
VitalDecades logo VitalDecades
Labs and biomarkers

How often does Medicare pay for a lipid panel? Every 5 years to screen, more often once you are treated

Brian Keller Healthcare Costs & Consumer Research
9 min read

Who made it and how it was checked

By Brian Keller, Healthcare Costs & Consumer Research. Researched and drafted with AI assistance, then edited by the editor named here. Fact-checked by Sarah Whitcomb, Senior Health Editor, . Its sources are listed on this page. No licensed clinician has reviewed it. How we source.

Report an error on this page

Medicare pays for a screening lipid panel once every 5 years, counted in months: no screening may be paid in the 59 months after the month of your last one. With a covered diagnosis such as high cholesterol, diabetes or high blood pressure, the test is diagnostic instead, and Medicare's national rule allows a yearly panel and, in the first year of treatment, any one part up to six times. A family history of heart disease or smoking, alone, does not count; a relative with familial hypercholesterolemia or high Lp(a) is on the code list, but a reviewer can still treat the test as screening.

Medicare pays for a cholesterol screening panel once every 5 years, counted in calendar months. Under 42 CFR 410.17, no screening may be paid in the 59 months after the month of your last one. By our count, a screening on March 22, 2022, can be repeated at no cost from March 1, 2027, not March 22, 2027. The 5-year limit stops applying once a covered condition is the reason for the test. Ordered for high cholesterol, diabetes, high blood pressure, kidney disease or a thyroid disorder, the panel is a diagnostic test under NCD 190.23, Medicare's national lipid rule. That rule treats a yearly panel as reasonable on treatment. It allows any single part of the panel up to six times in the first year of treatment.

On this page

Two rules for the same blood test

Codes like Z13.6 are the reason written on the order; five-digit codes like 80061 name the test.

Read November 16, 2026, from 42 CFR 410.17, NCD 190.23 and its October 2026 code list, CMS's claims manual (chapter 18, section 100) and the 2026 lab fee schedule.
Screening (42 CFR 410.17)Diagnostic (NCD 190.23)
WhoNo apparent signs or symptoms of heart or blood vessel diseaseA covered condition, or treatment that needs monitoring
How oftenOnce in 60 months (none paid in the 59 months after the month of the last one)Yearly panel on long-term treatment or with borderline-high cholesterol; one part up to six times in year one; total or LDL cholesterol three times a year once goals are met
Tests that countLipid panel (80061) or total cholesterol, HDL and triglycerides (82465, 83718, 84478)Those, plus a measured LDL (83721) and the advanced lipoprotein tests on the rule's code list (83700, 83701, 83704)
Reason on the orderThe screening code Z13.6The condition, such as hyperlipidemia (E78.5) or type 2 diabetes (E11.9)
What you pay (Original Medicare)$0 if the provider accepts assignmentUsually $0 for a covered diagnostic lab test
What Medicare pays the lab$13.39 for the panel; $18.28 if the three parts are billed one by one (our sum)Same rates

Count months, not years

The regulation's wording is "has not had the screening tests paid for by Medicare during the preceding 59 months following the month in which the last cardiovascular screening tests were performed." CMS's claims manual calls the same limit "once every 60 months." Read together, the count starts with the month after your last screening, and you become eligible in the same calendar month five years later. That is our reading of the rule, and it matches the way CMS's manual counts its other monthly screening limits.

Our arithmetic from 42 CFR 410.17(c). Confirm the date of your last Medicare-paid screening on your Medicare Summary Notice or with the lab before you book.
Last screening panel paid by MedicareFirst date a screening panel is paid again
March 22, 2022March 1, 2027
November 30, 2021November 1, 2026

In our reading, two things reset nothing: a diagnostic panel in between does not restart the screening clock, because the limit counts screening tests only, and a change of lab does not either, because the rule counts tests Medicare paid for, wherever they were done.

When the panel stops being screening

NCD 190.23 lists who can have lipid testing as a diagnostic test: people with heart or artery disease, primary or secondary lipid disorders (it names diabetes, gut absorption problems and chronic kidney failure), and diseases that change how the body handles fat, among them nephrotic syndrome, pancreatitis, liver disease and an under- or overactive thyroid. In the rule's October 2026 code list, high blood pressure (I10), obesity (E66.9), fatty liver (K76.0), stage 3 kidney disease and hypothyroidism are all covered diagnoses for the panel.

What does not move you out of the screening group is risk alone. The rule says: "Lipid testing in asymptomatic individuals is considered to be screening regardless of the presence of other risk factors such as family history, tobacco use, etc." Its October 2026 code list matches for the common cases: a family history of heart disease (Z82.49) and tobacco use (Z72.0) are not on it. Two narrower family histories are on it, with no restriction to particular tests: a family history of familial hypercholesterolemia (Z83.42) and of elevated lipoprotein(a) (Z83.430). If heart disease runs in your family and you have no other condition, the 5-year screening limit is the one that applies, and a yearly panel is likely to be denied; if a parent, brother or sister has familial hypercholesterolemia, tell the clinician, because that history is a coded reason.

How often once you are treated

  • Starting treatment: "Any one component of the panel or a measured LDL may be reasonable and necessary up to six times the first year for monitoring dietary or pharmacologic therapy."
  • On long-term treatment, or borderline-high cholesterol: a full panel once a year "will usually be adequate," with a total cholesterol or measured LDL for visits in between if triglycerides are not high.
  • At goal: total or LDL cholesterol "may be measured three times yearly after treatment goals have been achieved."
  • Marked elevations or a treatment change that is not working can justify more frequent tests.
  • No treatment advised: "If no dietary or pharmacological therapy is advised, monitoring is not necessary."
  • Unexplained liver test changes: a lipid panel "would generally not be indicated more than twice per year."
  • Advanced lipoprotein tests (codes 83700, 83701, 83704): "Electrophoretic or other quantitation of lipoproteins may be indicated if the patient has a primary disorder of lipoid metabolism."

For what your numbers mean at each age, see our guide to cholesterol levels by age.

What triggers a bill

A screening panel billed before the 60th month is rejected, and CMS's claims manual tells contractors to print the Medicare Summary Notice message "Medicare does not pay for this many services or supplies." Because this is a frequency limit, CMS lets labs hand out an Advance Beneficiary Notice routinely for it. If you sign that notice and choose to have the test, the lab may charge its usual fee, which CMS says "is not limited to the Medicare fee schedule." If a required notice was not given properly, you are generally not liable, under chapter 30 of CMS's claims manual. Our page on what a Medicare ABN for a lab test means covers the three options on the form.

A screening order also cannot carry extra tests. The screening code Z13.6 is covered only with the panel and its three parts, so an advanced lipoprotein test or a measured LDL added "to be thorough" at a screening visit falls outside the benefit unless a diagnostic reason applies. If you are paying cash for a panel instead, our lipid panel price comparison lists four sellers' prices and their fasting rules.

Medicare Advantage: federal rules (42 CFR 422.100(k)) bar deductibles, copays and coinsurance for in-network Medicare-covered preventive services, and cardiovascular screening blood tests are on that list. Diagnostic lab cost sharing is set by your plan, so check its evidence of coverage.

Who this may not fit

People with familial hypercholesterolemia, very high triglycerides, recent pancreatitis or a statin side effect being worked up are followed by their clinician on a diagnostic schedule, and the screening count does not apply to them. The 2004 regulation also defines the screening panel as one "performed after a 12-hour fasting period"; if your clinician says a nonfasting sample is fine, follow the clinician, and see our guide to nonfasting triglyceride levels for what changes in the numbers.

Chest pain or pressure, or sudden shortness of breath, is a reason to call 911, not to order a cholesterol test.

What we checked and what we did not

We read 42 CFR 410.17 on eCFR, NCD 190.23 through the CMS coverage database, the NCD's October 2026 diagnosis code list, chapter 18, section 100 and chapter 30, section 50 of CMS's claims manual, Medicare.gov's cardiovascular screening and diagnostic lab pages, the 2026 lab fee schedule and 42 CFR 422.100. We did not read any Medicare Advantage plan's lab cost sharing, and we did not test how a contractor's claim system counts dates in practice; the eligibility dates above are our reading of the rule's wording.

Every Medicare rate and coverage rule on this page was checked against the pages listed under Sources on November 16, 2026.

Frequently asked questions

How often does Medicare pay for a lipid panel?

As a screening test, once every 5 years: none is paid in the 59 months after the month of the last one. With a covered condition such as high cholesterol or diabetes, NCD 190.23 treats a yearly panel as reasonable on treatment, and allows one part of it up to six times in the first year.

Does Medicare cover a cholesterol test every year?

Only as a diagnostic test, when the order names a covered condition or treatment you are on. For people with no condition, the screening limit of once every 5 years applies.

Does a family history of heart disease let me get screened more often?

Not on its own. NCD 190.23 says testing in people without symptoms is screening "regardless of the presence of other risk factors such as family history, tobacco use, etc." Its code list does include a family history of familial hypercholesterolemia (Z83.42) and of elevated lipoprotein(a) (Z83.430), so ask whether either applies to you.

What does Medicare pay for a lipid panel in 2026?

$13.39 to the lab (code 80061), plus $9.34 if a blood draw is billed. On Original Medicare you usually pay nothing for a covered screening or diagnostic lab test.

9 sources

These are the sources this guide cites, with each source's date where it publishes one. How we source.

Read next

Medicare ABN for a lab test: what each option means

An Advance Beneficiary Notice (form CMS-R-131) is a lab's written warning, before the test, that Original Medicare may not pay. If you sign it and choose the test, the lab can bill its usual fee, which CMS says is not limited to Medicare's rate. CMS names three common reasons: a test Medicare does not cover for your condition, one ordered more often than its rules allow, and an experimental or research-use test. Option 1 keeps your right to appeal; Options 2 and 3 do not. A notice that breaks CMS's rules generally leaves you not liable. Read Nov 16, 2026.

Continue reading

Newsletter

One email a week: what changed, what it costs, what to do. Every item sourced and dated.

You're on the list. Look for your first issue next week.

No spam. Unsubscribe anytime.

Was this helpful?

Your feedback shapes what we cover next.

Thanks for letting us know.

If you found this useful, sign up for our newsletter to get more like this.

Thanks. What was missing?

Optional. We read every response.

Thanks.

We use this to prioritize the next round of edits.

Related Articles

More from Brian Keller

More in Labs and biomarkers